Abstract: A system for brand management using social networks comprising an application server, social network crawler software modules, third party service integration software modules, an analytics server, a report generator, a search engine, a behavioral analysis engine, a recommendation engine, and a database. A user registers and provides data pertaining to a brand. Upon retrieving content from a plurality of social networks pertaining to the brand, the analytics server module analyzes the content to a content value specific to the brand among members of the social networks. The behavioral analysis engine obtains content elements generated by a first member a social network and analyzes the first member's behavior to compute an audience value of the first member. The report generator prepares reports specific to the brand, the reports comprising at least indicia of content value, indicia of audience value, and recommendations for improving member engagement with the brand.

Abstract: A system for brand management using social networks comprising an application server, social network crawler software modules, third party service integration software modules, an analytics server, a report generator, a search engine, a behavioral analysis engine, a recommendation engine, and a database. A user registers and provides data pertaining to a brand. Upon retrieving content from a plurality of social networks pertaining to the brand, the analytics server module analyzes the content to a content value specific to the brand among members of the social networks. The behavioral analysis engine obtains content elements generated by a first member a social network and analyzes the first member's behavior to compute an audience value of the first member. The report generator prepares reports specific to the brand, the reports comprising at least indicia of content value, indicia of audience value, and recommendations for improving member engagement with the brand.

Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.

Abstract: A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form.

Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents; a process for preparing the dosage form.

Abstract: A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form.

Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.

Abstract: A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form.

Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents; a process for preparing the dosage form.